ArticleViruses2020

IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro.

Friedrich Hahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.